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Background. The pathophysiology of female genital schistosomiasis (FGS) is only partially understood. This
study aims to describe the histopathological ﬁndings, polymerase chain reaction (PCR) results, and gynecological
manifestations of FGS in women with different intensities of Schistosoma haematobium infection.
Methods. Women aged 15–35 years living in an S. haematobium-endemic area in Madagascar under-
went pelvic and colposcopic examinations. Small biopsy specimens were obtained from lesions and examined
histopathologically. Schistosoma PCR was done on urine, biopsy, cervicovaginal lavage, and genital mucosal surface
specimens.
Results. Sandy patches and rubbery papules were found in 41 of 118 women (35%). Rubbery papules reﬂected
an intense cellular immune reaction dominated by eosinophils, epithelial erosion, and viable ova. There was a
signiﬁcant decrease in the prevalence of rubbery papules with age, even after adjustment for urinary ova excretion.
The sandy patches with grains showed moderate cellular immune reaction and ova (viable and/or calciﬁed). They
were most prevalent in cases with low-intensity urinary S. haematobium infection. Forty-two percent of women with
Schistosoma-negative urine specimens had at least 1 genital specimen test positive for Schistosoma by PCR.
Conclusions. The results indicate a diversity of lesions caused by S. haematobium and a dynamic evolution of
the genital lesions. Schistosoma PCR may give an indication of the diagnosis.
Keywords. Schistosoma haematobium; female genital schistosomiasis (FGS); histopathology; polymerase chain
reaction (PCR); Madagascar; reproductive health.
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Schistosoma haematobium may cause pathology in the urinary
and genital tracts. In the urinary tract, morbidity is correlated
with intensity of infection, as indicated by the number of eggs
excreted in the urine [1]. Up to 75% of women excreting S. hae-
matobium ova in the urine may have ova in the lower genital
tract.
However, female genital schistosomiasis (FGS) may also
occur in the absence of urinary egg excretion [2, 3]. FGS is rarely
seen without use of a colposcope and is often overlooked even
by those who have this tool. In remote areas, where most pa-
tients live, the cost of the equipment, the logistical difﬁculties
associated with light sources, electricity, and clean instruments,
as well as the invasive nature of the biopsy and gynecological
examination, may result in failure to diagnose FGS. Further-
more, identiﬁcation of lesions requires several weeks of training
and inspection of the entire intravaginal surfaces, including the
fornices and the anterior and posterior vaginal walls [3]. The
clinical pathology of FGS was described in 1949, but there is
still a lack of diagnostic standards, partly because of the ethical
limitations in obtaining specimens appropriate for analysis
[3, 4]. Therefore, the pathophysiology of FGS is only partially
understood [3, 5–7]. Furthermore, neither gynecology nor
infectious diseases textbooks contain information about the
macroscopic manifestations of the disease.
This study aims to describe the clinical manifestations and
histopathological characteristics of genital mucosal schistoso-
miasis lesions and to study these ﬁndings in relation to Schisto-
soma DNA in genital tissue. The diagnostic potential of
specimens collected from the surfaces of the vagina and the cer-
vix were evaluated in women with high- and low-intensity
S. haematobium infection and in those without urinary S. hae-
matobium egg excretion.
MATERIALS AND METHODS
Study Area
The study was performed in the district of Miandrivazo in West-
ern Madagascar in 2010. It is an area mainly of subsistence rice
farming, with scattered tobacco farming. Five villages were in-
cluded that had similar socioeconomic conditions and healthcare
services. At the time of the study, the national antischistosomal
treatment program had not reached the district.
Study Design and Population
A community-based cross-sectional study was performed
among women 15–35 years of age. They had lived in the villages
for >5 years and had not been treated for schistosomiasis in the
past 2 years. Women who were pregnant or naive to sexual in-
tercourse were excluded. On the basis of microscopy ﬁndings
in 3 urine specimens, women were divided into the following
3 groups: women who had a mean egg count of >50 ova per
10 mL urine and were from 4 villages where schistosomiasis is
highly endemic (hereafter, the high-intensity group); women
who had a mean egg count of <20 ova per 10 mL and were
from the same villages as those in the high-intensity group
(hereafter, the low-intensity group); and microscopy-negative
women from a village where schistosomiasis has a low endemic-
ity (hereafter, the microscopy-negative group). Eligible women
who consented to the gynecological study were consecutively
enrolled by convenience until the planned number of partici-
pants was reached (Figure 1).
Medical History, Gynecological Inspection, and Colposcopy
A female physician (F. R.) performed a reproductive health in-
terview in the Malagasy language. Gynecological examination
and colposcopy took place in a custom-built mobile clinic.
Women menstruating on the day of the examination were
asked to come back later. Two female physicians (E. F. K. and
B. S. R.) examined the surfaces of the vulva, vagina, and cervix
according to a standardized protocol [8, 9]. The ﬁndings were
discussed until a consensus was reached.
Three FGS-associated lesions are described: (1) grainy sandy
patches, deﬁned as areas with distinct single or clusters of ob-
long grains (approximately 0.05 × 0.2 mm) in the cervicovaginal
mucosa [8]; (2) homogenous sandy patches, deﬁned as homo-
genous foci without detectable grains at 15 times the original
magniﬁcation [6, 8]; and (3) rubbery papules, previously de-
scribed in the urinary bladder mucosa only, deﬁned as spheroid,
ﬁrm, beige, smooth papules (size, 0.3–1.2 mm) in the cervico-
vaginal mucosa [10]. Malignant-looking lesions constituted
friable, ulcerative, and papillomatous surfaces with abnor-
mal blood vessels. Contact bleeding was deﬁned as fresh
blood originating from the mucosal surface upon insertion of
the speculum.
The exact location of the biopsy was documented by a pointer
and a photocolposcope (Olympus OSC 500, with a mounted
E420, 10.0 megapixels; Olympus America, Center Valley,
Pennsylvania). Biopsy specimens were collected with a small
2.3-mm biopsy forceps (Endo-Flex, Voerde, Germany) and pre-
served in 5% formaldehyde.
Histopathological Analysis
Each formaldehyde-preserved biopsy specimen was embedded
in parafﬁn. From each biopsy specimen, 10 sections with a
thickness of 5 µm were pooled for DNA isolation. The remain-
ing parts were cut into 3.5-µm thick sections until no more tis-
sue remained. Sections were stained with hematoxylin and eosin
for histopathological examination. Only biopsy specimens that
contained both epithelium and stroma were included because
S. haematobium ova are rarely found in the epithelium [11].
Diagnosis of Possible Confounding Bacterial and Viral Infection
Samples were collected by a swab (Micro Rheologics, Brescia,
Italy), placed in a tube (Genelock; Sierra Molecular, Sonora,
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California), frozen, and tested for Neisseria gonorrhoeae,
Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas
vaginalis (by an in-house test; Statens Serum Institut (SSI),
Copenhagen, Denmark), and Schistosoma DNA by polymerase
chain reaction (PCR) analysis. Ulcers were swabbed for PCR
analysis of herpes simplex virus type 2 andHaemophilus ducreyi
(SSI). One swab specimen (obtained and transported using the
Copan Universal Transport Medium kit; Copan Diagnostics,
Murrieta, California) was collected for detection of human pap-
illomavirus [12], and 1 swab specimen was placed in 0.5 mL of
sterile normal saline for microscopic examination for bacterial
vaginosis by the Amsel criteria [8]. Serum specimens were tested
by a rapid plasma reagin test (RPR 500; Newmarket Laboratories,
Kentford, United Kingdom) and a Treponema pallidum hemag-
glutination assay (ELITech Group, Puteaux, France). Urine spec-
imens were tested for N. gonorrhoeae (SSI), C. trachomatis (SSI),
M. genitalium (SSI), and T. vaginalis (SSI) by PCR.
Urine Filtration, Papanicolaou (Pap) Smears, and Schistosoma
PCR
Three consecutive urine samples were examined by microscopy
before women were invited to participate in the gynecological
investigation. For PCR analysis, a fourth urine sample was col-
lected on the day of the gynecological investigation. Cervicova-
ginal lavage was performed by spraying 10 mL of 0.9% NaCl on
the cervical and inner half of the vaginal surfaces, pulling it back
Figure 1. Inclusion into gynecological investigations for female genital schistosomiasis. Numbers of subjects are speciﬁed in parentheses. aNumber of women
who came forth after the information meetings in 5 villages; the total population count is unknown; bA total of 107 women were excluded because the Schis-
tosoma haematobium intensity did not match the study group requirements, 6 were pregnant, 13 had no history of sexual intercourse, 14 did not provide 3 urine
specimens, 10 had resided in the area for <5 years, 7 had received treatment in the past 2 years, and/or 4 were outside the age range. A woman may have had
several reasons for exclusion; cIntensity was determined by S. haematobium ova excretion in 3 urine specimens. High intensity was deﬁned as >50 ova per 10 mL,
and low intensity was deﬁned as <20 ova per 10 mL. The negative women were from a village with low schistosomiasis endemicity.
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into the syringe, and spraying again; the process was performed
4 times. A mucosal sterile swab was applied over the cervix and
vaginal walls and rinsed out in 1 mL of 0.9% NaCl. After the
ordinary deposition onto the Papanicolaou smear slide, the en-
docervical brush was rinsed out in 1.8 mL of 0.9% NaCl. A cy-
tobrush was applied to lesions. If there was no lesion, the brush
was moved over the cervix and vaginal walls. Each specimen was
collected in a preallocated site and sequence.
The Schistosoma genus-speciﬁc PCR was performed with
some minor modiﬁcations [13]. In brief, following a heating
step and treatment with sodium dodecyl sulphate and protein-
ase K, DNA was extracted from 200-µL samples, using QIAmp
spin columns (Qiagen Benelux; Venlo, the Netherlands). Pho-
cin herpesvirus 1 was added to the lysis buffer as an internal
control. The internal transcribed spacer 2–based real-time
PCR was used [13]. DNA isolation and set up of the PCR were
performed with a custom-made automated liquid handling station
(Hamilton, Switzerland). Ampliﬁcation, detection, and analysis
were performed with the CFX real-time detection system (Bio-
Rad laboratories). Negative and positive control samples were
included in each ampliﬁcation run. The Schistosoma PCR was
classiﬁed as strongly positive (threshold cycle [Ct], < 30), moder-
ately positive (30 ≤ Ct < 35), or weakly positive (35 ≤ Ct < 50)
[14]. All laboratories were blind to subject characteristics.
Ethical Considerations
Ethical clearance was granted by the Committee of Ethics at the
Ministry of Health in Madagascar (number 031-CE/MINSAN 4
June 2010). Human experimentation guidelines of the US De-
partment of Health and Human Services and/or those of the au-
thors’ institutions were followed in the conduct of the research.
To limit the risk of iatrogenic infection, the study was conduct-
ed in an area where human immunodeﬁciency virus had not
been found among 1341 tested individuals (Monthly Report,
DHS, Miandrivazo, 2008–2009). Furthermore, for the same
reason, biopsy specimens were only taken from persons with
FGS-associated lesions or suspicion of malignancy. A biopsy
was only to be performed if it was felt that the participating
woman would be able to abstain from sex or would consistently
use condoms for 2 weeks following biopsy. Only one woman
was excluded at this point of the investigation. Information
about the study was provided to potential participants in Mal-
agasy, and consent was received from participants in Malagasy.
A female physician (P. R.) explained the purpose of the study,
the procedures, the anticipated beneﬁts and possible negative
consequences of participation, matters of privacy and conﬁden-
tiality, and the possibility to withdraw at any point. Participants
were allowed to ask questions at any time. Illiterate women pro-
vided written consent by placing a ﬁngerprint on the consent
form, and literate women signed the consent form. The
women were asked conﬁrmative questions at every step until
completion of the examination and treatment. A copy of the
consent form was handed out to each study participant. After
the examination, women who had undergone biopsy were of-
fered condoms.
The patients were informed of the ﬁndings, effects, and pos-
sible side effects of treatment with praziquantel. Women with
egg excretion in urine or with FGS were offered a single dose
of praziquantel (40 mg/kg body weight). Sexually transmitted
infections (STIs) were treated in accordance with the Malagasy
syndromic approach. Those who withdrew from the study, sex
partners of participants, and other community members re-
ceived the same possibility of STI treatment with praziquantel,
and referrals in a neighboring location. All documentation was
coded. The code list linking personal identities and results was
stored securely in the Institut Pasteur de Madagascar.
Statistical Analysis
It was hypothesized that 40% of females in the low-intensity
group would have FGS, while <2% of women in the microscopy-
negative group would have FGS [3]. Assuming a 95% con-
ﬁdence interval (CI) and 80% power, a sample size of 22
women with low-intensity infection and 22 with microscopy-
negative ﬁndings would be needed to demonstrate a statistical
difference between the 2 groups. Likewise, it was found that
22 women with high-intensity infection were needed to com-
pare clinical manifestations in low- and high-intensity groups.
The sample size was increased to 40 women in each group to
compensate for uncertainties and withdrawals.
The Statistical Package for the Social Sciences, version 16.0
(IBM, New York, New York), and EpiInfo, version 3.2.2 (Center
for Disease Control and Prevention, Atlanta, Georgia), were
used for statistical analysis. χ2 tests the Fisher exact tests were
performed, and odds ratios (ORs), 95% CIs, and likelihood ra-
tios for trends were calculated. Logistic regression analysis was
used for variables with a P value of <.25 in the bivariate analysis.
RESULTS
Of the 323 women screened, 118 were eligible and consented to
the gynecological investigations (Figure 1). The median overall
age was 20.5 years (interquartile range [IQR], 18–25 years),
19 years (IQR, 17–23 years) in the high-intensity group,
22 years (IQR, 19–26 years) in the low-intensity group, and
23 years (IQR, 19–29 years) in the microscopy-negative
group. The median egg counts in groups 1 and 2 were 266
ova (IQR, 110–796 ova) and 4 ova (IQR, 1–9 ova), respectively.
Biopsies of 31 lesions were performed using a 2.3-mm punch.
Only 19 of these biopsy specimens contained stroma and could
be evaluated histopathologically.
Macroscopic and Colposcopic Findings
FGS was diagnosed in 41 women (35%) on the basis of ﬁnding
48 lesions (Table 1). These were rubbery papules (Figure 2A),
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sandy patches appearing as single or clustered grains (Fig-
ure 2B), and sandy patches appearing as homogenous yellow
sandy areas (Figure 2C). Rubbery papules and contact bleeding
were only found in women with eggs excreted in urine, with fre-
quencies of 15 of 79 (19%) and 16 of 79 (20%), respectively.
Rubbery papules decreased in prevalence as the intensity of
schistosomiasis decreased (Table 1). Sandy patches with grains,
however, were most prevalent in the low-intensity group. Twenty-
nine women (25%) were found to have abnormal mucosal blood
vessels (Figure 2D). One woman had a malignant-looking
lesion, which was conﬂuent with rubbery papules (not
shown). There was no overall association between the intensity
of urinary S. haematobium infection (as measured by egg excre-
tion in urine) and colposcopic ﬁndings (data not shown). There
was a signiﬁcant decrease in the prevalence of rubbery papules
with increasing age, even after adjustment for urinary ova excre-
tion (adjusted OR, 0.85; 95% CI, .74–.99; P = .037). Similarly,
the prevalence of sandy patches presenting as grains increased
with increasing age, although this was not signiﬁcant (adjusted
OR, 1.07; 95% CI, .98–1.17; P = .13). The prevalence of homo-
genous sandy patches was not associated with age (P = .82).
Histopathological Findings
Table 2 shows the results of the histopathological investigations.
Histopathological examination of the rubbery papules (Figure 2A)
showed S. haematobium ova surrounded in most cases by a signif-
icant eosinophil response and epithelial erosion (Splendore-Hoep-
pli phenomenon [15]). Eleven of the rubbery papules had stroma
adequate for histological evaluation. These contained a median
count of 8 Schistosoma ova per high-power ﬁeld (HPF; IQR,
2–12 ova/HPF), and there were viable eggs in 9 of 11 tissue
samples. Sandy patches appearing as single or clustered grains
were characterized by a more moderate immune reaction
(Figure 2B). Biopsy specimens revealed a median of 11 ova/
HPF (IQR, 2–48 ova/HPF). The malignant-looking lesion
contained viable and nonviable S. haematobium only; no
Table 1. Colposcopy Findings in 118 Study Participants, by Intensity of Urinary Schistosomiasis
Colposcopya
High-Intensity Urinary
S. haematobium
Infection, no. (%) (n = 40)b
Low-Intensity Urinary
S. haematobium
Infection, no. (%) (n = 39)b
No S. haematobium
Egg Excretion, no. (%)
(n = 39)b
Overall Colposcopy
Results, no. (%)
(n = 118)b
Likelihood
Ratio P value
Rubbery papulesc 9 (23) 6 (15) 0 (0) 15 (13) .001
Sandy patches
constituting grainsd
7 (18) 11 (28) 3 (8) 21 (18) .05
Sandy patches
appearing
homogenous,
yellow arease
2 (5) 3 (8) 7 (18) 12 (10) .15
Contact bleedingf 7 (18) 9 (23) 0 (0) 16 (14) .001
Abnormal mucosal
blood vesselsg
11 (28) 9 (23) 9 (23) 29 (25) .87
Papillomatous tumorh 4 (10) 1 (3) 2 (5) 7 (6) .36
Leukoplakiai 2 (5) 0 (0) 3 (8) 5 (4) .11
Polypj 2 (5) 0 (0) 2 (5) 4 (3) .19
Other tumork 1 (3) 1 (3) 1 (3) 3 (3) 1.00
Ulcerl 0 (0) 0 (0) 1 (3) 1 (1) .33
Malignant-looking
lesionm
1 (3) 0 (0) 0 (0) 1 (1) .33
a One patient may have several types of lesions
b Intensity was determined on the basis of Schistosoma haematobium ova excretion in 3 urine specimens. High intensity was defined as >50 ova per 10 mL, and low
intensity was defined as <20 ova per 10 mL. Individuals with no eggs detected were from a village of low endemicity. See “Materials and Methods” section for
additional details.
c Smooth, spheroid, pustuloid, and firm beige papules of different size in the cervicovaginal epithelium.
d Distinct, oblong grains approximately 0.05 by 0.2 mm in the cervicovaginal epithelium.
e Sandy-looking areas without distinct grains in the cervicovaginal epithelium.
f Bleeding from the cervical epithelium at just slight touch of the surface during examination.
g Convoluted (cork screw), reticular, circular and/or branched, unevenly calibered blood vessels in the cervicovaginal mucosa.
h Sessile mass in the mucosa or vulva; whitish in color and often with a cauliflower-like appearance.
i Elevated white plaque on the mucosal surface, visible with or without acetic acid.
j Smooth, pedunculated mass originating from the cervicovaginal mucosal surface.
k Tumor not included in any of the other definitions.
l Demarcated area with loss of the epithelial layer; deep or superficial.
m Friable, ulcerative, papillomatous surface and abnormal blood vessels.
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neoplastic cells were detected. Neither dysplasia nor atypia
were seen in the biopsy specimens. Other lesion types were
not biopsied.
PCR Results
Table 3 shows the PCR results related to lesion type. Only rub-
bery papules and sandy patches were biopsied, but other
Figure 2. Manifestations of female genital schistosomiasis on the cervix uteri. A, Rubbery papules are smooth, ﬁrm, like a rubber ball, they constitute
viable ova and a rich eosinophilic reaction. B, Grainy sandy patches constitute calciﬁed and occasional viable ova. C, Homogenous sandy patch. D, Abnormal
blood vessels.
Table 2. Histological Results for 118 Study Participants
Gynecological Findinga
(No. of Biopsy
Specimensb) Ova Viability, No.c
Ova Density,
Median
(Range)d
Tissue
Eosinophiliae
Overall Tissue Immune
Response
Epithelial
Hyperplasiae
Patient Age,
y Median
(Range)
Rubbery papules
(n = 11)
Viable, 9; calcified,
2; mixed, 0
8 (1–14) Mild, 4;
moderate, 3;
marked, 4
Moderate, 3; marked,
8
Moderate, 9;
marked, 2
19 (15–25)
Sandy patches
constituting grains
(n = 4)
Viable, 3; calcified,
1; mixed, 1
11 (2–80) None, 1; mild, 2;
moderate, 1
Moderate, 3; marked,
1
None, 1; mild, 2;
moderate, 1
23 (15–32)
The biopsied homogenous sandy patches, patient median age 20 years (range 15–35) did not contain stroma and were not adequate for histopathological
examination with regard to schistosomiasis.
a By colposcopy.
b Biopsy specimens with sufficient amount of stroma for examination of schistosome ova.
c Ovawere defined as viable if miracidial structures such as eosinophilic glands or germinal cells were identified, whereas ova containing a dark purple stain identified
histologically as calcification were defined as calcified.
d Median (range) of ≥1 section per lesion per high-power field.
e Hyperplasia of squamous epithelium in ectocervical biopsy specimens.
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specimens were PCR positive even in the absence of FGS-asso-
ciated lesions. Table 4 shows PCR ﬁndings in relation to the 3
intensity groups. A greater percentage of women with eggs de-
tected in urine than women with microscopy-negative ﬁndings
had Schistosoma-positive genital specimens. However, 42% of
the microscopy-negative women had at least 1 PCR-positive
genital specimen. Urine specimens tested positive by PCR for
all women with high-intensity infection. Only 62% of women
with low-intensity infection had PCR-positive urine specimens.
Thirteen percent of women in the microscopy-negative group
had PCR-positive urine specimens.
All 15 women with rubbery papules had PCR-positive
specimens and high levels of Schistosoma DNA. Tables 3
and 5 show that <50% of the lesions with grains tested positive
by PCR. Sandy patches appearing as homogenous yellow
areas yielded PCR-positive results in 42%–58%. Only 70% of
women (20 of 31) who underwent biopsy under the suspicion
of genital schistosomiasis had PCR-positive specimens. Only
1 of 14 women with histopathologically veriﬁed S. haematobium
ova had a PCR-negative specimen. There was no signiﬁcant as-
sociation between any of the tested sexually transmitted dis-
eases and the presence of rubbery papules, sandy patches,
contact bleeding, or abnormal mucosal blood vessels (data
not shown).
DISCUSSION
This population study describes a lesion in the cervicovaginal
mucosa that has not been reported to date. We have named it
“rubbery papule” because of its ﬁrm consistency and spherical
Table 3. Polymerase Chain Reaction (PCR) Results for 118 Study Participants, by Specimen Tested
Colposcopy Findinga
Targeted Lesion
Biopsy Specimen
Cervicovaginal
Lavage Fluid
Mucosal Swab
Specimen
Endocervical Brush
Specimen
Lesion Brush
Specimen
Rubbery papulesb (4 also had GSP or
HSP)
11/13 (85) 15/15 (100) 15/15 (100) 10/15 (67) 13/15 (87)
Sandy patches constituting grainsc (5
also had RP and/or HSP)
7/10 (70) 10/21 (48) 5/21 (24) 5/21 (24) 4/18 (22)
Sandy patches appearing
homogenous, yellow areasd (3 also
had GSP, and/or RP)
3/4 (75) 7/12 (58) 6/12 (50) 6/12 (50) 5/12 (42)
Contact bleedinge (14 also had RP,
GSP, or HSP)
NA 11/16 (69) 9/16 (56) 7/16 (56) 10/16 (63)
Abnormal mucosal blood vesselsf (22
also had RP, GSP, or HSP)
NA 15/28 (54) 11/28 (39) 8/29 (28) 12/28 (43)
Papillomatous tumorg (2 also had RP,
GSP, and /or HSP)
NA 2/3 (67) 2/3 (67) 0/3 (0) 2/3 (67)
Leukoplakiah (2 also had RP, GSP,
and/or HSP)
NA 4/5 (80) 3/5 (60) 2/5 (40) 3/5 (60)
Polypi (2 also had RP, GSP, or HSP) NA 2/4 (50) 1/4 (25) 1/4 (25) 1/3 (33)
Other tumorj (2 also had RP, GSP,
and/or HSP)
NA 2/3 (67) 2/3 (67) 2/3 (67) 3/3 (100)
Ulcerk (the patient also had HSP) NA 0/1 (0) 0/1 (0) 0/1 (0) 0/1 (0)
Malignant-looking lesionl (the patient
also had RP and HSP)
1/1 (100) 1/1 (100) 1/1 (100) 1/1 (100) 1/1 (100)
Data are no. of participants with specimens testing positive/no. tested (%). PCR results are considered positive regardless of the strength (ie, strong, moderate, or
weak) of the positive response (see Table 5).
Abbreviations: GSP, sandy patches constituting grains; HSP, sandy patches appearing homogenous, yellow areas; NA, not applicable; RP, rubbery papules.
a One patient may have several types of lesions.
b Spheroid, pustuloid, and firm beige papules of different size in the cervicovaginal epithelium.
c Distinct, oblong grains approximately 0.05 by 0.2 mm in the cervicovaginal epithelium.
d Sandy-looking areas without distinct grains in the cervicovaginal epithelium.
e Bleeding from the cervical epithelium at just slight touch of the surface during examination.
f Convoluted (cork screw), reticular, circular and/or branched, unevenly calibered blood vessels in the cervicovaginal mucosa.
g Sessile mass in the mucosa or vulva; whitish in color and often with a cauliflower-like appearance.
h Elevated white plaque on the mucosal surface, visible with or without acetic acid.
i Smooth, pedunculated mass originating from the cervicovaginal mucosal surface.
j Tumor not included in any of the other definitions.
k Demarcated area with loss of the epithelial layer; deep or superficial.
l Friable, ulcerative, papillomatous surface and abnormal blood vessels.
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and papulous appearance. The rubbery papule constitutes se-
vere eosinophilic inﬂammation, mostly around viable-looking
ova. Women with this lesion tested positive for Schistosoma
by PCR, which is in agreement with the presence of viable
ova. The prevalence of the rubbery papules was the highest in
teenagers. This could suggest recent infection and lesions in
an early stage. Sandy patches constituted more-moderate in-
ﬂammation, and not all patients had PCR-positive ﬁndings, as
has been reported previously [8]. Genital contact bleeding, rub-
bery papules, and sandy patches were found signiﬁcantly more
often in patients with urine specimens positive for S. haema-
tobium eggs.
The sandy patches have been described in previous studies on
the African continent. To our knowledge, our study in Mada-
gascar is the ﬁrst to document rubbery papules in the genitalia.
Morphologically similar lesions were observed in the bladder by
cystoscopy in Egypt in 1946 [10]. Subsequent studies have men-
tioned “whitish or yellowish, occasional conﬂuent, mucosal
dots” found in the genital region of humans and primates
[16, p 442]. It is possible that these were rubbery papules. A re-
view of 4000 images by some of the current authors, from pre-
vious studies in Malawi, Zimbabwe, and South Africa, showed
no such lesions [17]. It is therefore possible that local Malagasy
factors might have affected the manifestations of FGS, such
as the schistosome strain, the genetic differences between
Malagasy and the Africa mainland human populations, or
local nutritional factors [18–22].
The coexistence of tissue eosinophilia and viable ova indicate
ongoing ova deposition from living worms, whereas the calci-
ﬁed ova and moderate inﬂammation indicate that ova were
deposited some time ago. This pattern concurs with the grading
scale for bladder pathologies published by Von Lichtenberg et al
in the 1970s [6, 7, 16]. Although good effect of treatment has
been reported for urinary bladder pathology, it has been sug-
gested that the sandy patches are established in childhood
and are a result of a chronic infection [7, 23–25]. People living
in Schistosoma-endemic areas are often exposed from infancy
[26]. Women have had worms (and possibly also lesions) for
many years by the time they undergo a gynecological investiga-
tion. The ﬁnding of calciﬁed ova, therefore, could indicate that
the sandy patches might be a manifestation of childhood infec-
tion and that it may not be easy to treat as has been indicated
previously in one report [25].
Women in the high-intensity group had a higher probability
of having genital specimens positive for Schistosoma by PCR,
rubbery papules, and sandy patches. This might indicate con-
tamination from the urinary tract. However, the specimens
were taken by a syringe with an extension tip in the inner
third of the vagina. Furthermore, some cases with Schistoso-
ma-urine negative specimens (ie, women with no ova and no
Schistosoma DNA in urine) were found to have Schistosoma
DNA in genital specimens. This may indicate that the 2 organs
need not be affected synchronously. The genital tests were better
in diagnosing FGS than PCR or microscopy of urine specimens,
although contamination between the organs cannot be preclud-
ed. Even so, this study conﬁrms that the genital sampling meth-
ods and PCR analysis are not sufﬁcient [27].
Because of ethical concerns, only women with sandy patches,
rubbery papules, and/or malignant-looking lesions underwent
biopsy. This posed a major limitation to the study and made
Table 4. Schistosoma Polymerase Chain Reaction Findings in Different Specimens from 118 Study Participants, by Intensity of Urinary
Schistosomiasis
Specimen Type
High-Intensity Urinary
S. haematobium Infectiona
Low-Intensity Urinary
S. haematobium Infectiona
No S. haematobium
Egg Excretiona
All Groups
Combined
Likelihood
Ratio P value
Cervicovaginal
lavageb
30/40 (75.0) 18/39 (46.2) 7/38 (18.4) 55/117 (47.0) <.001
Mucosa swabc 24/40 (60.0) 12/39 (30.8) 8/38 (21.1) 44/117 (37.6) .001
Endocervical
brushd
14/39 (35.9) 5/39 (12.8) 4/39 (10.3) 23/117 (19.7) .009
Lesion brushe 29/38 (76.8) 14/35 (40.0) 4/31 (12.9) 47/104 (45.2) <.001
Urine 40/40 (100) 24/39 (61.5) 5/39 (12.8) 69/118 (58.5) <.001
Data are no. of participants with specimens testing positive/no. tested (%). Denominators within columns vary owing to missing data.
a Intensity was determined on the basis of Schistosoma haematobium ova excretion in 3 urine specimens. High intensity was defined as >50 ova per 10 mL, and low
intensity was defined as <20 ova per 10 mL. Individuals with no eggs detected were from a village of low endemicity. See “Materials and Methods” section for
additional details.
b A total of 10 mL of 0.9% NaCl was sprayed on the cervical and inner half of the vaginal surfaces, pulled it back into the syringe, and sprayed again; the process was
performed 4 times.
c A sterile swab was applied over the cervix and vaginal walls and rinsed in 1 mL of 0.9% NaCl.
d The endocervical brush that had been used for Papanicolaou smear was rinsed in 1.8 mL of 0.9% NaCl following the ordinary deposition unto the Papanicolaou
smear slide.
e A cytobrush was applied to lesions suspected to be caused by schistosomiasis. If there was no lesion, the brush was moved over the cervix and the vaginal walls.
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it impossible to calculate sensitivity and speciﬁcity. Likewise,
blood vessels were not biopsied for fear of causing severe bleed-
ing. The sample size was limited, and the results indicate that
there were no true-negative controls, as is unfortunately the
case for most schistosomiasis research [4, 9, 11]. A small biopsy
punch was chosen to make targeted biopsies of lesions. Howev-
er, even when surfaces did not look edematous or inﬂamed, the
genital tissue of these nonpregnant women was unusually soft,
and biopsy specimens were difﬁcult to obtain. We had never en-
countered such soft tissue in the thousands of women examined
in our previous work in Zimbabwe, Malawi, and South Africa
[8, 9], and hence this small biopsy punch was not useful as
we had anticipated.
This study adds rubbery papules to the list of genital lesions
associated with S. haematobium infection in females. The ﬁnd-
ings conﬁrm that live and dead S. haematobium ova may cause
pathology in genital tissue [27]. Further, patients with a series of
Schistosoma-negative results of urine tests may have Schistosoma
DNA in genital specimens. In this population, Schistosoma PCR
contributed to the diagnosis of rubbery papules, but it was not
strong in the diagnosis of sandy patches and abnormal blood ves-
sels, which may constitute inﬂammation around dead ova. At the
point of care, clinical inspection must be the mainstay for diag-
nosis, and in research it should be combined with one of the lab-
oratory tests [28]. Further studies are needed to explore the
clinical algorithms that may lead to diagnosis at the point of
care and diagnostic tools that can objectively identify the lesions.
Moreover, it is not known what the different lesions represent in
terms of health risks and symptoms. Studies are needed to
explore the health effects of the different lesions, including the
abnormal mucosal blood vessels. Finally, the optimal timing of
anti-schistosomal treatment [29] and the implications for infec-
tions by agents such as human immunodeﬁciency virus and
human papillomavirus should be explored.
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Table 5. Graded Schistosoma Polymerase Chain Reaction (PCR) Results, by Lesion Type
Lesion Type, Specimen
Type
Strongly Positive PCR,
No. (%)
Moderately Positive PCR,
No. (%)
Weakly Positive PCR,
No. (%)
Negative PCR,
No. (%)
Likelihood Ratio
P value
Rubbery nodules
Cervicovaginal lavagea
(n = 15)
15 (100) 0 (0) 0 (0) 0 (0) <.001
Mucosal swabb (n = 15) 11 (74) 2 (13) 2 (13) 0 (0) <.001
Endocervical brushc
(n = 15)
4 (27) 4 (27) 2 (13) 5 (33) <.001
Lesion brushd (n = 13) 12 (92) 1 (8) 0 (0) 0 (0) <.001
Sandy patches appearing as single or clustered grains
Cervicovaginal lavagea
(n = 21)
4 (19) 0 (0) 6 (29) 11 (52) .08
Mucosal swabb (n = 21) 4 (19) 1 (5) 0 (0) 16 (76) .13
Endocervical brushc
(n = 21)
3 (14) 2 (10) 0 (0) 16 (76) .18
Lesion brushd (n = 18) 4 (22) 0 (0) 0 (0) 14 (78) .01
Sandy patches appearing as homogenous yellow areas
Cervicovaginal lavagea
(n = 12)
6 (50) 0 (0) 1 (8) 5 (42) .24
Mucosal swabb (n = 12) 5 (42) 1 (8) 0 (0) 6 (50) .13
Endocervical brushc
(n = 12)
2 (17) 3 (25) 1 (8) 6 (50) .08
Lesion brushd (n = 10) 5 (50) 0 (0) 0 (0) 5 (50) .04
Schistosoma PCR results were classified as strongly positive (threshold cycle [Ct], < 30), moderately positive (30 ≤Ct < 35), or weakly positive (35≤Ct < 50).
a A total of 10 mL of 0.9% NaCl was sprayed on the cervical and inner half of the vaginal surfaces, pulled it back into the syringe, and sprayed again; the process was
performed 4 times.
b A sterile swab was applied over the cervix and vaginal walls and rinsed in 1 mL of 0.9% NaCl.
c The endocervical brush that had been used for Papanicolaou smear was rinsed in 1.8 mL of 0.9% NaCl following the ordinary deposition unto the Papanicolaou
smear slide.
d A cytobrush was applied to lesions suspected to be caused by schistosomiasis. If there was no lesion, the brush was moved over the cervix and the vaginal walls.
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